Nature of Collaboration Sample Clauses

Nature of Collaboration. This/These programme(s) shall be [Joint/Franchised/Validated/OTHER/Collaborative Research] collaborative programmes, as defined by the University’s Learning and Quality Enhancement Handbook (LQEH)1.
Sample 1
AutoNDA by SimpleDocs
Nature of Collaboration. 3.1 XXXXX and MEDICHEM hereby mutually agree to cooperate with each other to form a COMPANY for the purpose of taking the COMPOUND through its clinical trials which shall start as soon as such trials are approved by the FDA and to comply with and achieve the Benchmarks for the development thereof as set out in APPENDIX D to the Patent License Agreement between MEDICHEM and the National Institutes of Health (further set out in Appendix C hereof). 3.2 The COMPANY shall seek the requisite approvals of the FDA and any other governing bodies (hereinafter referred to as "the regulatory authorities") for the conduct of clinical trials for the COMPOUND and comply with all the conditions and requirements set out in the approvals by the regulatory authorities. 3.3 The COMPANY shall seek the approvals of the regulatory authorities in the United States of America and those of other countries for the manufacture, use, marketing and sale of the PRODUCT.
Sample 1
Nature of Collaboration. The Parties declare that: (a) Each is a non-profit research organization, whose primary goal is to provide healthcare services and conduct fundamental and clinical research and to disseminate its results by way of teaching, publication or technology transfer; (b) That the collaboration according to this Agreement is solely of non-economic nature as it covers only non-economic activities between collaborating research organizations only; and (c) That any profits are reinvested into these primary activities: the dissemination of their results, research and related clinical practice or educational purposes, consistent with the Parties’ missions.
Sample 1
Nature of Collaboration. 1. This agreement is entered into among Universities of the “EU Ph.D. Consortium on Metamaterials”, listed as Parties. 2. The Universities of the Consortium will each appoint one faculty member as Delegate to administer the “EU Ph.
Sample 1
Nature of Collaboration. This MOU shall be valid initially for three (3) years from the date of execution from both the Parties and extendable further as per the need of both the parties. Both the parties shall take reasonable steps to ensure the successful completion of the Collaboration and shall cooperate with each other, in the performance of their respective Obligations in Staff and Student Exchange Programmes (S & S E P). Each party shall be at liberty to terminate this MOU with a written notice period of three months to the other party without any compensation and selecting legal redress. Further, protection and exploitation of any data and/or intellectual property rights that arise as a result of any research or activity will be agreed on a case-to-case basis. This MOU is signed subject to approval of the respective academic/administrative bodies and not intended to be legally binding, nor to create any evidence or imply any contract obligation to enter into a contract or obligation to negotiate. Principal
Sample 1
Nature of Collaboration. 1.1 The collaboration between the Parties shall be in the planning and implementation of a predetermined and mutually agreed upon research project. 1.2 The Parties have agreed to cooperate in the research on “Investigation of pathogenic variation of Asian soybean rust pathogen and development of resistant soybean varieties in Bangladesh” (hereinafter referred to as “Project”). 1.3 When there is a need for other forms of collaboration, these will be discussed, agreed upon and implemented by the Parties.
Sample 1
Nature of Collaboration. In consideration for the work to be performed under this Agreement, the College and the Company have, in accordance with the provisions of the Statement of Work attached hereto, mutually developed cost proposals, goals, objectives, deliverables, timelines, funding contributions, the participation by each of the Parties and the anticipated contribution to the research results, and identified the remuneration specific to each element of the Project. For all subsequent collaborative proposals, all of the foregoing elements shall also be incorporated as a Statement of Work applicable to such Project, and finalized by mutual agreement within thirty
Sample 1
AutoNDA by SimpleDocs
Nature of Collaboration. 2.1. This MoU is for enhancing the campus placement percentage by using Business standard for entry level Skilling & Recruitment. 2.2. The primary purpose of this MoU is to set terms for use of Bussiness standard For automated campus recruitment and pre-placement / post placement skilling process.
Sample 1

Related to Nature of Collaboration

  • Scope of Collaboration As part of the collaboration, the Controllers will act as Joint Controller. The roles of the Controller and the associated tasks are specified in more detail in Appendix 1. If one party is solely responsible for a data processing operation, this party will implement all relevant data protection provisions on its own responsibility. However, such data processing procedures are not subject to this Agreement. Joint data processing and the type of Personal Data collected and processed within the framework of collaboration are specified in Appendix 1.

  • Research Collaboration 3.7.1 Aarvik shall carry out the activities of each Work Item and deliver the required Data Package and/or deliverables in accordance with the applicable SOW. Without limiting the generality of the foregoing, Aarvik shall, in accordance with the applicable SOWs and the timeline approved by JRC, apply the Aarvik IP to (i) design and synthesize Collaboration Compounds, and (ii) by itself or through subcontractor(s), [***]. During the Research Term, if any Party identifies any Third Party Patent or Know-How that is necessary or reasonably useful for any activity under the SOWs but has not been included in the Aarvik IP, then such Party shall immediately inform the other Party and the Parties shall discuss in good faith the need of obtaining a license from such Third Party. 3.7.2 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver the Data Packages and all other deliverables required under the [***], as well as the results of the Patentability and FTO Analysis as described in Section 3.2.3, to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.3 If, upon completion of the [***] for the Collaboration Program, AxxxXxxx decides not to advance the Collaboration Program to [***], ArriVent may terminate the Collaboration Program. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.4 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. 3.7.5 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. 3.7.6 Within [***] ([***]) days after completion of the [***], Aarvik shall deliver to ArriVent a full report on all key results and findings of the Collaboration Program, and such other data, results and information as ArriVent may deem necessary for it to determine whether or not to exercise the Option (the “Full Report”).

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Reformulation of Products As of the Effective Date, and continuing thereafter, Products that Xxxxx directly manufactures, imports, distributes, sells, or offers for sale in California shall either: (a) be Reformulated Products pursuant to § 2.2, below; or (b) be labeled with a clear and reasonable exposure warning pursuant to §§ 2.3 and 2.4, below. For purposes of this Settlement Agreement, a “Reformulated Product” is a Product that is in compliance with the standard set forth in

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Research Program The term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto.

  • For clarity the time allowances provided in clause 2.10 shall operate to reduce the maximum timetabled classroom teaching time specified in clause 4.2 of this agreement.

  • Research Project The findings of any research project, which would change the provisions of this Agreement will not be implemented until such changes are negotiated and agreed to by the parties.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!